作者
Carlo Patrono, Fedor Bachmann, Colin Baigent, Christopher Bode, Raffaele De Caterina, Bernard Charbonnier, Desmond Fitzgerald, Jack Hirsh, Steen Husted, Jan Kvasnicka, Gilles Montalescot, Luis Alberto García Rodríguez, Freek Verheugt, Jozef Vermylen, Lars Wallentin, Silvia G Priori, Maria Angeles Alonso Garcia, Jean-Jacques Blanc, Andrzej Budaj, Martin Cowie, Veronica Dean, Jaap Deckers, Enrique Fernández Burgos, John Lekakis, Bertil Lindahl, Gianfranco Mazzotta, João Morais, Ali Oto, Otto A Smiseth, João Morais, Jaap Deckers, Rafael Ferreira, Gianfranco Mazzotta, Philippe-Gabriel Steg, Frederico Teixeira, Robert Wilcox
发表日期
2004/1/1
来源
European heart journal
卷号
25
期号
2
页码范围
166-181
出版商
Oxford University Press
简介
The role of aspirin and other platelet-active drugs in the treatment and prevention of atherothrombosis has been reviewed recently by the Sixth American College of Chest Physicians (ACCP) Consensus Conference on Antithrombotic Therapy 1 (available online at www. chestnet. org). Moreover, updated information on the efficacy and safety of antiplatelet therapy is provided by the collaborative meta-analysis of 287 secondary prevention trials, prepared by the Antithrombotic Trialists’(ATT) Collaboration 2 (available online at www. bmj. com). The purpose of the present guidelines is to integrate a mechanistic understanding as to why some antiplatelet drugs work and some do not, with an evidence-based definition of categories of patients for whom the benefits of antiplatelet therapy clearly outweigh the risk of bleeding complications. Recommendations concerning the use of individual antiplatelet agents will also be …
引用总数
学术搜索中的文章
C Patrono, F Bachmann, C Baigent, C Bode… - European heart journal, 2004